Health & Environmental Research Online (HERO)


Print Feedback Export to File
7189109 
Journal Article 
[Low dose naltrexone in the treatment of dissociative symptoms] 
Pape, W; Wöller, W; , 
2015 
Yes 
Der Nervenarzt
ISSN: 0028-2804
EISSN: 1433-0407 
German 
25421416 
Following the hypothesis that blocking opioid receptors leads to a decline in opiate-modulated dissociative phenomena, experiences with naltrexone as medication for dissociative symptoms have been gained since 1999 (mainly in doses of 25-100 mg/day).